# Senior Director, Pharmacovigilance at Braveheart

- Company: Braveheart
- What the company does: Advancing treatments to improve outcomes and quality of life for patients with hypertrophic cardiomyopathy and related heart conditions. Backed by a16z.
- Company website: https://www.braveheart.bio
- Type: Startups
- Level: Principal and up
- Location: San Francisco, CA or Remote or Hybrid
- Work setup: Remote
- Pay: $230K to $325K base salary per year (USD)
- Posted: 2026-09-10
- Apply by: 2026-10-25
- Apply: https://job-boards.greenhouse.io/braveheartbio/jobs/4400907009
- Page: https://www.1752.vc/careers/jobs/braveheart-senior-director-pharmacovigilance/

## About the role

The Senior Director, Pharmacovigilance (PV) will serve as a key leader within Braveheart Bio's Drug Safety and Pharmacovigilance organization, partnering closely with the Vice President, Drug Safety and Pharmacovigilance to execute the company's global drug safety and pharmacovigilance strategy and ensure excellence in pharmacovigilance operations, safety surveillance, signal management, aggregate reporting, vendor oversight, and regulatory compliance.

## What they're looking for

- Degree in Health Care is required (e.g., MD, DO, PhD, NP, Pharm D)
- Strong knowledge of global regulations governing pharmacovigilance in the pharmaceutical industry and Research & Development processes
- Experience authoring and/or overseeing aggregate safety reports, including DSURs, PBRERs/PSURs, IND Annual Reports, Investigator Brochures, and Reference Safety Information (RSI)
- Experience with safety surveillance, signal detection, signal evaluation, benefit-risk assessment, and risk management activities
- Experience in writing safety sections (e.g., Clinical Safety Summaries [Module 2.7.4], ISS, ISE, narratives) of marketing applications, and successfully defending contents to Health Authorities
- Experience supporting global regulatory submissions, including INDs, CTAs, NDA/BLA/MAA submissions, and responses to Health Authority safety queries

Tags: Pharmacovigilance